COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
52North is a Cambridge med‑tech company developing NeutroCheck, a portable finger‑prick device and AI-enabled digital platform for at‑home and clinical triage of neutropenic sepsis risk.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
